Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy PLx Pharma stock

Own PLx Pharma stock in just a few minutes.

PLx Pharma Inc is a drug manufacturers-specialty & generic business based in the US. PLx Pharma shares (PLXP) are listed on the NASDAQ and all prices are listed in US Dollars. PLx Pharma employs 8 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in PLx Pharma

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – PLXP – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

PLx Pharma share price

Use our graph to track the performance of PLXP stocks over time.

PLx Pharma shares at a glance

Information last updated 2021-04-23.
52-week range$2.36 - $11.15
50-day moving average $9.14
200-day moving average $6.31
Wall St. target price$16.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-3.87

Buy PLx Pharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy PLx Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

PLx Pharma financials

Revenue TTM $30,430
Gross profit TTM $30,430
Return on assets TTM -37.29%
Return on equity TTM -191.61%
Profit margin 0%
Book value $-1.50
Market capitalisation $242.4 million

TTM: trailing 12 months

Shorting PLx Pharma shares

There are currently 805,984 PLx Pharma shares held short by investors – that's known as PLx Pharma's "short interest". This figure is 8.8% up from 740,481 last month.

There are a few different ways that this level of interest in shorting PLx Pharma shares can be evaluated.

PLx Pharma's "short interest ratio" (SIR)

PLx Pharma's "short interest ratio" (SIR) is the quantity of PLx Pharma shares currently shorted divided by the average quantity of PLx Pharma shares traded daily (recently around 629675). PLx Pharma's SIR currently stands at 1.28. In other words for every 100,000 PLx Pharma shares traded daily on the market, roughly 1280 shares are currently held short.

However PLx Pharma's short interest can also be evaluated against the total number of PLx Pharma shares, or, against the total number of tradable PLx Pharma shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case PLx Pharma's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 PLx Pharma shares in existence, roughly 40 shares are currently held short) or 0.0381% of the tradable shares (for every 100,000 tradable PLx Pharma shares, roughly 38 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against PLx Pharma.

Find out more about how you can short PLx Pharma stock.

PLx Pharma share dividends

We're not expecting PLx Pharma to pay a dividend over the next 12 months.

Have PLx Pharma's shares ever split?

PLx Pharma's shares were split on a 1:8 basis on 19 April 2017. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your PLx Pharma shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for PLx Pharma shares which in turn could have impacted PLx Pharma's share price.

PLx Pharma share price volatility

Over the last 12 months, PLx Pharma's shares have ranged in value from as little as $2.36 up to $11.15. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PLx Pharma's is 5.1526. This would suggest that PLx Pharma's shares are significantly more volatile than the average for this exchange and represent a higher risk.

PLx Pharma overview

PLx Pharma Inc. , a specialty pharmaceutical company, focuses on developing the PLxGuard drug delivery system to provide various products in the United States. The company's lead product candidates are Vazalore 325 mg and Vazalore 81 mg, which are formulations of aspirin that use the PLxGuard delivery system, which provides patients with vascular disease and diabetic patients who are candidates for aspirin therapy based on physician recommendation, with fast, reliable, and predictable platelet inhibition as compared to enteric-coated aspirin, as well as reduces the risk of stomach erosions and ulcers as compared with immediate-release aspirin, after seven days of treatment. Its product pipeline also includes other oral nonsteroidal anti-inflammatory drugs using the PLxGuard drug delivery system, such as PL1200 Ibuprofen 200 mg and PL1200 Ibuprofen 400 mg, which are in Phase I clinical stage for pain and inflammation, as well as PL1100 Ibuprofen 400 mg. PLx Pharma Inc. was founded in 2002 and is headquartered in Sparta, New Jersey. .

Frequently asked questions

What percentage of PLx Pharma is owned by insiders or institutions?
Currently 18.228% of PLx Pharma shares are held by insiders and 22.416% by institutions.
How many people work for PLx Pharma?
Latest data suggests 8 work at PLx Pharma.
When does the fiscal year end for PLx Pharma?
PLx Pharma's fiscal year ends in December.
Where is PLx Pharma based?
PLx Pharma's address is: 9 Fishers Lane, Sparta, NJ, United States, 07871
What is PLx Pharma's ISIN number?
PLx Pharma's international securities identification number is: US72942A1079
What is PLx Pharma's CUSIP number?
PLx Pharma's Committee on Uniform Securities Identification Procedures number is: 25456J104

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site